Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
03/2003
03/26/2003EP1294398A2 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
03/26/2003EP1294397A2 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
03/26/2003EP1294395A1 A COMBINATION PRODUCT COMPRISING MELAGATRAN AND A FACTOR VIIa INHIBITOR
03/26/2003EP1294394A1 A COMBINATION PRODUCT COMPRISING MELAGATRAN AND A FACTOR Xa INHIBITOR
03/26/2003EP1294393A2 Glycosylphosphatidylinositol specific phospholipase d proteins for the treatment and diagnosis of athersclerosis
03/26/2003EP1294390A2 The use of copolymer 1 and related peptides and polypeptides and t cells treated therewith for neuroprotective therapy
03/26/2003EP1294385A1 Method for the production of artificial oxygen carriers from covalently cross linking haemoglobin with improved functional properties of haemoglobin by cross-linking in the presence of chemically non-reacting effectors of the oxygen affinity of the haemoglobin
03/26/2003EP1294384A2 Use of lanthanum compounds for the treatment of bone diseases
03/26/2003EP1294380A1 A method for treating septic shock
03/26/2003EP1294378A2 Thrombopoietin mimetics
03/26/2003EP1294377A2 Methods and compositions for the treatment of alcoholism and alcohol dependence
03/26/2003EP1294367A2 Oral compositions comprising host-response modulating agent
03/26/2003EP1294366A1 Pharmaceutical compounds for treating copd
03/26/2003EP1294349A2 Use of egf-r protein tyrosine kinase inhibitors for preventing photoaging in human skin
03/26/2003EP1294227A2 Transgenic mice containing nuclear hormone receptor gene disruptions
03/26/2003EP1225810B1 Method for treatment of chronic venous insufficiencies using an extract of red vine leaves
03/26/2003EP1200431B1 Quinuclidine derivatives and their use as muscarinic m3 receptors ligands
03/26/2003EP1185528A4 Inhibitors of il-12 production
03/26/2003EP1181010A4 Pharmaceutical chewing gum formulations
03/26/2003EP1173215A4 Over-coated chewing gum formulations
03/26/2003EP1159269B1 Anti-imflammatory indole derivatives
03/26/2003EP1146873A4 Anti-androgens and methods for treating disease
03/26/2003EP1105384B1 Diarylbenzopyran derivatives as cyclooxygenase-2 inhibitors
03/26/2003EP1091948B1 Tubulin binding compounds (cobra)
03/26/2003EP1086249B1 Diagnostic method based on quantification of extramitochondrial dna
03/26/2003EP1083906A4 Aminosugar, glycosaminoglycan, and s-adenosylmethionine composition for the treatment and repair of connective tissue
03/26/2003EP1066292B1 Metallocorrinoids as biologically compatible carriers of pharmacological agents
03/26/2003EP1041969B1 Novel pharmaceutical compositions of uridine triphosphate
03/26/2003EP1025085B1 Heterocycles useful in the treatment of benign prostatic hyperplasia and intermediates thereof
03/26/2003EP1011346B1 Animal feed containing carboxylic acids
03/26/2003EP0998477B1 Alkyl-4-silylheterocyclic phenols and thiophenols as antioxidant agents
03/26/2003EP0998454B1 Metalloproteinase inhibitors
03/26/2003EP0977748B1 Substituted benzopyran derivatives for the treatment of inflammation
03/26/2003EP0946186B1 Stomach submucosa derived tissue graft
03/26/2003EP0871653B1 Novel amino acid derivatives, methods of producing them, and pharmaceutical compounds containing these compounds
03/26/2003EP0863757B1 2-substituted aryl pyrroles, compositions containing such compounds and methods of use
03/26/2003EP0763026B1 Gastrin and cck antagonists
03/26/2003CN1406280A Progenitor cell preservation factors and related methods and products
03/26/2003CN1406276A Sericin-containing material, Process for producing the same and method of using the same
03/26/2003CN1406233A Medicine for viral diseases
03/26/2003CN1406231A Pyrimidine compounds
03/26/2003CN1406230A 2,4-di (hetero-) arylamino (-oxy)-5-substituted pyrimidines as antineoplastic agents
03/26/2003CN1406229A Pyrimidine compounds
03/26/2003CN1406228A 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents
03/26/2003CN1406227A Aryl fused azapolycy clic compounds
03/26/2003CN1406225A Quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists
03/26/2003CN1406223A Protease inhibitor and their pharmaceutical uses
03/26/2003CN1406137A Caspase activated prodrugs therapy
03/26/2003CN1406132A Method for treating or inhibiting cellular injury or cell death
03/26/2003CN1404829A Double inhibitor synthesized by wax ester and cholesterol ester for inbibiting generation of sebum
03/26/2003CN1103782C Mono-pegylated MGDF polypeptide
03/26/2003CN1103775C Vitronectin receptor antagonists, their preparation and use
03/26/2003CN1103772C Novel 2,3-disubstituted-4 (3H)-quinazolinone
03/26/2003CN1103770C Quino xaline diones
03/26/2003CN1103755C Novel structural analogues of vitamin D
03/26/2003CN1103593C Synergistic composition
03/26/2003CN1103590C Use of thiazolidinediones to prevent or delay on set of NIDDM
03/26/2003CA2423858A1 Novel proteins, genes encoding them and method of using the same
03/25/2003WO2003000254A1 Fused cyclic compounds and medicinal use thereof
03/25/2003WO2002026260A1 Preventives/remedies for emotional disorders
03/25/2003US6538149 Aryl or heteroaryl substituted 3,4-dihydroanthracene and aryl or heteroaryl substituted benzo [1,2-g]chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivatives having retinoid antagonist or retinoid inverse agonist type biological activity
03/25/2003US6538144 P-thienylbenzylamides as agonists of angiotensin-(1-7) receptors, and methods of their preparation and use
03/25/2003US6538121 Interleukin-1 β converting enzyme like apoptosis protease-3 and 4
03/25/2003US6538037 Inhibiting the hyperproliferation of malignant or neoplastic cells by treating the cells with an antiproliferative amount of 1 alpha ,24(S)-dihydroxyvitamin D2 the cells being cancers of the lung, neck and head, pancreas, endometrium, bladder
03/25/2003US6538034 Methods of treating or preventing weight gain, obesity, and related disorders
03/25/2003US6538021 Method for producing luteolin and luteolin derivatives
03/25/2003US6538017 Anticoagulants; cardiovascular disorders; central nervous system disorders
03/25/2003US6538008 Combination of a selective NMDA NR2B antagonist and an opioid analgesic
03/25/2003US6537995 Heterocyclic carboxamides
03/25/2003US6537993 Compounds for enhancing chemotherapy
03/25/2003US6537992 Regulation of organic nitrate tolerance
03/25/2003US6537991 A method of treating a peripheral neuropathic pain in a warm-blooded animal requiring such treatment which comprises administering to said animal a therapeutically effective amount of an EP1-type prostaglandin receptor antagonist
03/25/2003US6537990 Combined preparations comprising morpholine anthracyclines and anticancer agent
03/25/2003US6537988 Synergistic methods and compositions for treating cancer
03/25/2003US6537984 Contacting a targeted solid tumor cell population with a combination of a vinca alkaloid selected from vinblastine, vincristine, vinorelbine, and a triptolide in combination dosage to reduce the targeted tumor cell population
03/25/2003US6537980 Vitamin D analogues and their pharmaceutical use
03/25/2003US6537969 Nutritional supplement for cerebral metabolic insufficiencies
03/25/2003US6537965 Novel parathyroid hormone (PTH) peptide derivatives. In particular, the invention relates to PTH PTH-2 receptor agonist or antagonist properties to the derivatives.
03/25/2003US6537812 Methods for the production of TcRγδ+ T cells
03/25/2003US6537785 Methods of treating lysosomal storage diseases
03/25/2003US6537784 Self-regulated apoptosis of inflammatory cells by gene therapy
03/25/2003US6537591 Aquatic animal treatment method and composition containing Pimenta extract
03/25/2003US6537573 Combination dosage form comprising cetirizine and pseudoephedrine
03/25/2003US6537524 Inflammatory or obstructive airways disease
03/25/2003CA2423800A1 Fused cyclic compounds and medicinal use thereof
03/25/2003CA2423364A1 Preventives/remedies for emotional disorders
03/25/2003CA2237221C Protein kinase c inhibitor
03/25/2003CA2224093C Human vascular endothelial growth factor 2
03/25/2003CA2079034C Respiratory disease vaccine for cats
03/25/2003CA2065496C Treatment of aphthous ulcers and other mucocutaneous disorders
03/21/2003WO2002026230A1 Remedies for inflammatory bowel diseases
03/21/2003CA2423423A1 Medecines of ulcerative colitis
03/20/2003WO2003023054A1 New assay for inhibitors of translocases
03/20/2003WO2003023045A1 Sulfated polysaccharides, process for producing the same and substances having the same as the active ingredient
03/20/2003WO2003022995A2 Nucleic acid and corresponding protein entitled steap-1 useful in treatment and detection of cancer
03/20/2003WO2003022886A1 Igf-1 as feline vaccine adjuvant, in particular against feline retroviruses
03/20/2003WO2003022882A2 Method of increasing the contractility of a heart, a heart muscle or cells of a heart muscle
03/20/2003WO2003022871A2 Peptides having a c- terminal hydroxylamino group as inhibitors of dipeptidyl peptidase i
03/20/2003WO2003022853A1 Method for the preparation of hexahydro-furo[2,3-b]furan-3-ol
03/20/2003WO2003022852A2 Furo-and thienopyrimidine derivatives as angiogenesis inhibitors
1 ... 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 820 821 822 823 824 825 ... 1564